Acute carotid occlusion or near-occlusion with concomitant intracranial embolism cause severe acute ischemic strokes in patients. These concomitant occlusions have suggested poor response to intravenous thrombolysis and complicate endovascular treatment. Nevertheless, endovascular stent-assisted thrombectomy may improve outcome in patients but the treatment is not without concerns. Required antiplatelet therapy to prevent stent thrombosis may increase the rate of intracranial hemorrhage, especially after recent thrombolysis. Furthermore, technical difficulties in access of the intracranial vasculature may cause adverse events, even in the hands of experienced interventionalists. These concerns currently defy the treatment in being recommended for general use and only on a compassionate basis. However, recent patient series have suggested reasonable safety and efficacy for carotid stent-assisted thrombectomy.
KEYWORDS• antiplatelet hemorrhage • atherosclerosis • carotid stent-assisted thrombectomy • stroke dissection Acute ischemic stroke (AIS) is the leading cause of acquired long-term disability and the fourth most cause of death [1]. Severity of AIS varies from minor focal neurological deficits to life-threatening hemispheric syndromes. Severe AIS caused by an occlusion of a large intracranial artery comprise 15-20% of all AIS [2,3]. In approximately 20-30% of patients with a large intracranial occlusion a concomitant occlusion or near-occlusion is found in the ipsilateral extracranial internal carotid artery (ICA) [4,5]. This extracranial occlusion is thought to be the origin of the intracranial occlusion by artery to artery embolism. A carotid occlusion or near-occlusion can be caused by an arterial dissection or atherosclerotic plaque and discrimination may have impact on peri-and post-procedural management. Although ICA lesions can cause cerebral ischemia in different ways, such as by compromised hemodynamic or microemboli with impaired washout, this review will only focus on ICA lesions with concomitant intracranial emboli in the acute stroke setting.Due to the high oxygen requirement of brain tissue, expeditious management is crucial for reversal of ischemia and successful salvage of the ischemic tissue at risk [6]. Intravenous thrombolysis (IVT) with administration of intravenous recombinant plasminogen activator (iv-tPA) is currently the recommended treatment for AIS within 4.5 h of symptom onset [7,8]. However, in patients suffering moderate-to-severe AIS from acute large vessel occlusions, IVT is often ineffective [9,10]. Studies suggest clinical improvement in only 20-30% of patients with this configuration of large vessel occlusions with IVT alone [10][11][12][13].Carotid endarterectomy (CEA) is not the preferred option, as surgery would only address the extracranial carotid occlusion without access to the intracranial occlusion that would require intra-arterial management [14]. Furthermore, surgery is not advocated to repair carotid dissections.Endovascular therapy (EVT) with mechanical thrombectom...